What do Analysts suggest for: Provectus

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz
199

What do Analysts suggest for: Provectus Biopharmaceuticals, Inc. (OTCVCT)
By Adam Smith -
Mar 3, 2017
0
13

Some buy side analysts are also providing their Analysis on Provectus Biopharmaceuticals, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 1 Analysts reported that the Price Target for Provectus Biopharmaceuticals, Inc. might touch $3.5 high while the Average Price Target and Low price Target is $3.5 and $3.5 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Provectus Biopharmaceuticals, Inc. got Upgrade on 7-Apr-09 where investment firm Rodman & Renshaw Upgrade the stock from Mkt Perform to Mkt Outperform.
Finance 2
00:00
Share
Playlist
Link

Copy to clipboard: Ctrl+C / Cmd+C
Embed

Copy to clipboard: Ctrl+C / Cmd+C

Provectus Biopharmaceuticals, Inc. closed its last trading session at $0.03 with the loss of -14.91%. The Market Capitalization of the company stands at 8.57 Million. The Company has 52-week high of $0.54 and 52-week low of $0.01. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 9.69% where SMA50 and SMA200 are 25.17% and -84.09% respectively. The Company Touched its 52-Week High on Apr 29, 2016 and 52-Week Low on Dec 21, 2016.

The Relative Volume of the company is 3.18 and Average Volume (3 months) is 4.21 million. Provectus Biopharmaceuticals, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Provectus Biopharmaceuticals, Inc. currently shows a Weekly Performance of -8.91%, where Monthly Performance is 40.72%, Quarterly performance is 55.63%, 6 Months performance is -81.42% and yearly performance percentage is -95.1%. Year to Date performance value (YTD perf) value is 19.9%. The Stock currently has a Weekly Volatility of 60.24% and Monthly Volatility of 26.02%.
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Diana Shipping's Q3 2025 Performance and Upcoming Dividend

Updated Category News Views 144

Diana Shipping Inc. Financial Highlights for Q3 2025 In a recent financial disclosure, Diana Shipping Inc. (NYSE: DSX), a notable global player in the dry bulk shipping sector, announced earnings for the third quarter of 2025. The company's net income reached $7.2 million, marking a significant increase from $3.7 million reported in the same quarter last year. This...

Continue Reading
Martela Corporation Reveals Interim Results for Early 2024

Updated Category News Views 184

Financial Performance Overview Martela Corporation has recently published its interim report for the period from January to September 2024. This report highlights a decline in revenue and operating success compared to previous periods, while also illustrating a positive trend in new orders during the third quarter. This update is crucial for stakeholders to understand the...

Continue Reading
CME Group Preps Investors for Q2 2026 Results

Updated Category News Views 6

A Sharp Eye on CME Group's Upcoming Reveal Mark July 22 on your calendar, folks, because that's when CME Group Inc. will drop its second-quarter 2026 earnings. If you're in the trading game, these numbers can whip up a storm of speculation about where this powerhouse of the derivatives world is headed. With their earnings release dropping bright and early before markets...

Continue Reading
FirstEnergy Foundation Spreads Holiday Cheer with $40,000 Donations

Updated Category News Views 125

FirstEnergy Foundation's Generosity This Holiday Season This year, the FirstEnergy Foundation has embraced the spirit of giving by surprising several agencies in Maryland and West Virginia with generous donations totaling $40,000. Such efforts highlight their commitment to enhancing the local communities where they operate. Community Support through Holiday Giving As part...

Continue Reading
Hyperfast Title Joins reAlpha's AI Homebuying Platform

Updated Category Stocks Views 322

reAlpha Acquires 85% Stake in Hyperfast Title, LLC 85% of Hyperfast Title, LLC. has been acquired by reAlpha Tech Corp. Hyperfast calls Florida, Virginia, and Tennessee home. This purchase expands the portfolio of reAlpha with title and settlement services. Re Alpha is renowned for creating real estate artificial intelligence technologies. The purchase from Madison...

Continue Reading